UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.048

Sortiert nach

Systematic literature review examining patient and investigator satisfaction with abobotulinumtoxinA treatment in aesthetic indications

Toxicon (Oxford), 2018, Vol.156, p.S96-S97

2018

Volltextzugriff (PDF)

Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation

International journal of nanomedicine, 2019-01, Vol.14, p.1953-1968

2019

Volltextzugriff (PDF)

Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment

International journal of nanomedicine, 2019-08, Vol.14, p.6555-6574

2019

Volltextzugriff (PDF)

Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension

Colloids and surfaces, B, Biointerfaces, 2018-05, Vol.165, p.37-44

2018

Volltextzugriff (PDF)

Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion

Regulatory toxicology and pharmacology, 2016-12, Vol.82, p.20-31

2016

Volltextzugriff (PDF)

Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment

International journal of pharmaceutics, 2016-05, Vol.505 (1-2), p.147-158

2016

Volltextzugriff (PDF)

Efficacy and safety of olmesartan medoxomil‐amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single‐arm, multi‐center, real‐world study

The journal of clinical hypertension (Greenwich, Conn.), 2024-01, Vol.26 (1), p.5-16

2024

Volltextzugriff (PDF)

Identification, Synthesis, and Comprehension of an Imidazole N‑3 Regioisomeric Impurity of Olmesartan Medoxomil Key Intermediate

Organic process research & development, 2022-04, Vol.26 (4), p.1247-1257

2022

Volltextzugriff (PDF)

Olmesartan-associated Enteropathy Mimics Endoscopic Findings of Celiac Disease

Internal Medicine, 2020, pp.4336-19

2020

Volltextzugriff (PDF)

Fabrication of Nanosuspension Directly Loaded Fast-Dissolving Films for Enhanced Oral Bioavailability of Olmesartan Medoxomil: In Vitro Characterization and Pharmacokinetic Evaluation in Healthy Human Volunteers

AAPS PharmSciTech, 2018-07, Vol.19 (5), p.2118-2132

2018

Volltextzugriff (PDF)

Formulation of lyophilized oily-core poly-Ɛ-caprolactone nanocapsules to improve oral bioavailability of Olmesartan Medoxomil

Drug development and industrial pharmacy, 2020-05, Vol.46 (5), p.795-805

2020

Volltextzugriff (PDF)

Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability

Colloids and surfaces, B, Biointerfaces, 2017-06, Vol.154, p.10-20

2017

Volltextzugriff (PDF)

Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk

Toxicology and applied pharmacology, 2019-02, Vol.364, p.120-132

2019

Volltextzugriff (PDF)

Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation

Drug development and industrial pharmacy, 2017-04, Vol.43 (4), p.611-617

2017

Volltextzugriff (PDF)

Coupling of synchronous fluorescence spectroscopy with derivative amplitude outcomes for simultaneous determination of metoprolol succinate and olmesartan medoxomil in combined pharmaceutical preparation: Application in spiked human plasma

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2023-06, Vol.294, p.122549, Article 122549

2023

Volltextzugriff (PDF)

Positively charged self-nanoemulsifying oily formulations of olmesartan medoxomil: Systematic development, in vitro, ex vivo and in vivo evaluation

International journal of pharmaceutics, 2015-09, Vol.493 (1-2), p.466-482

2015

Volltextzugriff (PDF)

Formulation, optimization, and in vitro–in vivo evaluation of olmesartan medoxomil nanocrystals

Drug delivery and translational research, 2017-04, Vol.7 (2), p.292-303

2017

Volltextzugriff (PDF)

Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors

Advances in therapy, 2023-11, Vol.40 (11), p.4817-4835

2023

Volltextzugriff (PDF)

Bioavailability Enhancement of Olmesartan Medoxomil Using Hot-Melt Extrusion: In-Silico, In-Vitro, and In-Vivo Evaluation

AAPS PharmSciTech, 2020-09, Vol.21 (7), p.254, Article 254

2020

Volltextzugriff (PDF)

Development and validation of a stability‐indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple‐combination dosage form using factorial design of experiments

Biomedical chromatography, 2021-11, Vol.35 (11), p.e5194-n/a

2021

Volltextzugriff (PDF)

Digging Deep Into Diarrhea

Gastroenterology (New York, N.Y. 1943), 2023-10, Vol.165 (4), p.e19-e22

2023

Volltextzugriff (PDF)

Bioequivalence Study of a New Fixed-Dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects

Clinical therapeutics, 2017-07, Vol.39 (7), p.1371-1379

2017

Volltextzugriff (PDF)

Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability

Drug development and industrial pharmacy, 2017-07, Vol.43 (7), p.1186-1196

2017

Volltextzugriff (PDF)

Design and development of a self-microemulsifying drug delivery system of olmesartan medoxomil for enhanced bioavailability

Drug development and industrial pharmacy, 2019-08, Vol.45 (8), p.1292-1305

2019

Volltextzugriff (PDF)

Formulation and In-vitro Evaluation of Bilayer Tablet of Olmesartan Medoxomil for Biphasic Drug Release

INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE, 2023-06, Vol.14 (2), p.388-392

2023

Volltextzugriff (PDF)

1 – 25 von 1.048

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(961)
Mit Volltextzugriff
(921)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(757)
Life Sciences & Biomedicine
(709)
Olmesartan Medoxomil
(529)
Humans
(521)
Olmesartan
(481)
Male
(443)
Hypertension - Drug Therapy
(342)
Tetrazoles - Therapeutic Use
(307)
Imidazoles - Therapeutic Use
(303)
Female
(301)
Hypertension
(299)
Pharmacology & Pharmacy
(284)
Cardiovascular System & Cardiology
(264)
Blood Pressure - Drug Effects
(239)
Animals
(235)
Middle Aged
(233)
Antihypertensive Agents - Therapeutic Use
(227)
Peripheral Vascular Disease
(200)
Aged
(195)
Tetrazoles - Pharmacology
(192)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Systematic literature review examining patient and investigator satisfaction with abobotulinumtoxinA treatment in aesthetic indications

Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation

Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment

Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension

Comparative biodistribution and safety profiling of olmesartan medoxomil oil-in-water oral nanoemulsion

Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment

Efficacy and safety of olmesartan medoxomil‐amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single‐arm, multi‐center, real‐world study

Identification, Synthesis, and Comprehension of an Imidazole N‑3 Regioisomeric Impurity of Olmesartan Medoxomil Key Intermediate

Olmesartan-associated Enteropathy Mimics Endoscopic Findings of Celiac Disease

Fabrication of Nanosuspension Directly Loaded Fast-Dissolving Films for Enhanced Oral Bioavailability of Olmesartan Medoxomil: In Vitro Characterization and Pharmacokinetic Evaluation in Healthy Human Volunteers

Formulation of lyophilized oily-core poly-Ɛ-caprolactone nanocapsules to improve oral bioavailability of Olmesartan Medoxomil

Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability

Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk

Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation

Coupling of synchronous fluorescence spectroscopy with derivative amplitude outcomes for simultaneous determination of metoprolol succinate and olmesartan medoxomil in combined pharmaceutical preparation: Application in spiked human plasma

Positively charged self-nanoemulsifying oily formulations of olmesartan medoxomil: Systematic development, in vitro, ex vivo and in vivo evaluation

Formulation, optimization, and in vitro–in vivo evaluation of olmesartan medoxomil nanocrystals

Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors

Bioavailability Enhancement of Olmesartan Medoxomil Using Hot-Melt Extrusion: In-Silico, In-Vitro, and In-Vivo Evaluation

Development and validation of a stability‐indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple‐combination dosage form using factorial design of experiments

Digging Deep Into Diarrhea

Bioequivalence Study of a New Fixed-Dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects

Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability

Design and development of a self-microemulsifying drug delivery system of olmesartan medoxomil for enhanced bioavailability

Formulation and In-vitro Evaluation of Bilayer Tablet of Olmesartan Medoxomil for Biphasic Drug Release

Suchergebnisse filtern